Complexo Hospitalario Universitario de Lugo
Centro de atención
Francisco Javier
Narváez García
Publicacións nas que colabora con Francisco Javier Narváez García (20)
2024
-
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383
2023
-
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81
2022
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis
Reumatologia Clinica, Vol. 18, Núm. 8, pp. 443-452
-
SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Reumatologia Clinica, Vol. 18, Núm. 9, pp. 501-512
2021
-
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
Scientific Reports, Vol. 11, Núm. 1
2019
-
Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
2015
-
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility
American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580
2014
-
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82
2013
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886
2012
-
Assessment of cardiovascular risk in rheumatoid arthritis: Impact of the new EULAR recommendations on the score cardiovascular risk index
Clinical Rheumatology, Vol. 31, Núm. 1, pp. 35-39
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
2011
-
A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601
-
Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 38, Núm. 5, pp. 889-892
-
Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis
Human Immunology, Vol. 72, Núm. 5, pp. 458-461
-
Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 29, Núm. 1 SUPPL. 64
2010
-
Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2076-2080
-
Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 37, Núm. 11, pp. 2331-2333